BRIEF-Resverlogix announces positive recommendation from data safety monitoring board for Apabetalone phase 3 study
August 11, 2016 at 07:45 AM EDT
* Resverlogix announces positive recommendation from data safety monitoring board for phase 3 study of Apabetalone (rvx-208)